Host-pathogen coevolution in human tuberculosis

被引:268
作者
Gagneux, Sebastien [1 ,2 ]
机构
[1] Swiss Trop & Publ Hlth Inst, Dept Med Parasitol & Infect Biol, CH-4002 Basel, Switzerland
[2] Univ Basel, CH-4002 Basel, Switzerland
基金
瑞士国家科学基金会; 美国国家卫生研究院; 英国医学研究理事会;
关键词
mycobacteria; infection; virulence; genotyping; phylogeography; fitness; MYCOBACTERIUM-TUBERCULOSIS; TRADE-OFF; EVOLUTION; STRAINS; VIRULENCE; TRANSMISSION; RETHINKING; DIVERSITY; MIGRATION; AMERICAN;
D O I
10.1098/rstb.2011.0316
中图分类号
Q [生物科学];
学科分类号
090105 [作物生产系统与生态工程];
摘要
Tuberculosis (TB) is a disease of antiquity. Yet TB today still causes more adult deaths than any other single infectious disease. Recent studies show that contrary to the common view postulating an animal origin for TB, Mycobacterium tuberculosis complex (MTBC), the causative agent of TB, emerged as a human pathogen in Africa and colonized the world accompanying the Out-of-Africa migrations of modern humans. More recently, evolutionarily 'modern' lineages of MTBC expanded as a consequence of the global human population increase, and spread throughout the world following waves of exploration, trade and conquest. While epidemiological data suggest that the different phylogenetic lineages of MTBC might have adapted to different human populations, overall, the phylogenetically 'modern' MTBC lineages are more successful in terms of their geographical spread compared with the 'ancient' lineages. Interestingly, the global success of 'modern' MTBC correlates with a hypo-inflammatory phenotype in macrophages, possibly reflecting higher virulence, and a shorter latency in humans. Finally, various human genetic variants have been associated with different MTBC lineages, suggesting an interaction between human genetic diversity and MTBC variation. In summary, the biology and the epidemiology of human TB have been shaped by the long-standing association between MTBC and its human host.
引用
收藏
页码:850 / 859
页数:10
相关论文
共 73 条
[1]
The success and failure of BCG - implications for a novel tuberculosis vaccine [J].
Andersen, P ;
Doherty, TM .
NATURE REVIEWS MICROBIOLOGY, 2005, 3 (08) :656-662
[2]
[Anonymous], WHOCDSTB2003
[3]
[Anonymous], 2006, GLOB PLAN STOP TB 20
[4]
Silent nucleotide polymorphisms and a phyogeny for Mycobacterium tuberculosis [J].
Baker, L ;
Brown, T ;
Maiden, MC ;
Drobniewski, F .
EMERGING INFECTIOUS DISEASES, 2004, 10 (09) :1568-1577
[5]
Are the PE-PGRS proteins of Mycobacterium tuberculosis variable surface antigens? [J].
Banu, S ;
Honoré, N ;
Saint-Joanis, B ;
Philpott, D ;
Prévost, MC ;
Cole, ST .
MOLECULAR MICROBIOLOGY, 2002, 44 (01) :9-19
[6]
The spectrum of latent tuberculosis: rethinking the biology and intervention strategies [J].
Barry, Clifton E., III ;
Boshoff, Helena I. ;
Dartois, Veronique ;
Dick, Thomas ;
Ehrt, Sabine ;
Flynn, JoAnne ;
Schnappinger, Dirk ;
Wilkinson, Robert J. ;
Young, Douglas .
NATURE REVIEWS MICROBIOLOGY, 2009, 7 (12) :845-855
[7]
Transmission of Mycobacterium tuberculosis from patients smear-negative for acid-fast bacilli [J].
Behr, MA ;
Warren, SA ;
Salamon, H ;
Hopewell, PC ;
de Leon, AP ;
Daley, CL ;
Small, PM .
LANCET, 1999, 353 (9151) :444-449
[8]
The equilibria that allow bacterial persistence in human hosts [J].
Blaser, Martin J. ;
Kirschner, Denise .
NATURE, 2007, 449 (7164) :843-849
[9]
Borrell S, 2009, INT J TUBERC LUNG D, V13, P1456
[10]
A new evolutionary scenario for the Mycobacterium tuberculosis complex [J].
Brosch, R ;
Gordon, SV ;
Marmiesse, M ;
Brodin, P ;
Buchrieser, C ;
Eiglmeier, K ;
Garnier, T ;
Gutierrez, C ;
Hewinson, G ;
Kremer, K ;
Parsons, LM ;
Pym, AS ;
Samper, S ;
van Soolingen, D ;
Cole, ST .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (06) :3684-3689